This inventor holds 1 USPTO granted patent. Top assignees: Shanghaitech University, University of Toronto. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 88 
1 out of 530 
Years Active: 2025
Title: The Innovations of Donghui Wu
Introduction
Donghui Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. His work focuses on advancing medical treatments and diagnostics for various diseases.
Latest Patents
Donghui Wu holds a patent for "Human antibodies to human interleukin 18 receptor alpha or beta." This patent includes antibodies or fragments that specifically bind to the IL-18 receptor alpha or beta. The methods described in the patent are aimed at treating and diagnosing diseases such as cancer, as well as inflammatory and autoimmune diseases.
Career Highlights
Throughout his career, Donghui Wu has been associated with prestigious institutions such as ShanghaiTech University and the University of Toronto. His work at these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in his field.
Collaborations
Some of his notable coworkers include Sachedv S Sidhu and Haiming Huang. Their collaborative efforts have further enhanced the impact of his research and innovations.
Conclusion
Donghui Wu's contributions to biotechnology and his innovative patent on human antibodies highlight his role as a key figure in medical research. His work continues to pave the way for new treatments and diagnostic methods for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile